Executive Perspective For organizations investing in Cushing's syndrome, commercial planning typically focuses on clinical differentiation, market access, pricing, physician adoption, and competitive positioning. These are all critical components of a successful launch. However, they all depend on one event that occurs much earlier. A patient must first be correctly diagnosed. Unlike many therapeutic areas where multiple therapies compete for a well-defined patient population, Cushing's syndrome presents a different commercial challenge…
Full article
Full article available by request only.
Contact PharmaKonsult to request the complete opinion paper.